Insider Trading & Ownership of Colin Love

Location
Woburn, MA
Summary
The estimated net worth of Colin Love is at least $5,029,422 dollars as of 20 May 2024. Colin Love is the Chief Operating Officer of Replimune Group, Inc. and owns shares of Replimune Group, Inc. (REPL) stock worth about $5.03M.
Signature
/s/ Shawn Glidden, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Colin Love and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Colin Love has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $5,029,422.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Replimune Group, Inc. ($5,029,422).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Colin Love

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
REPL Replimune Group, Inc. Chief Operating Officer $5,029,422 16 May 2024

Insider Transactions Reported by Colin Love:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .